Tag Archive for Revenue

LifeVantage Revenue Fiscal Year 2022 Down 6% To $206.4 Million

LifeVantage Corporation today reported financial results for its fourth quarter and full fiscal year ended June 30, 2022.
Fourth Quarter Fiscal 2022 Summary*:
Revenue of $50.9 million, a decrease of 7.0% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was down approximately 3%;

Revenue in Asia/Pacific & Europe increased 0.7%
Revenue in the Americas decreased 10.5%.
Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue in Asia/Pacific & Europe increased approximately 12.8%;
Total active accounts declined 8.2% from the prior period to 156,000, reflecting a 10.9% decline in the Americas and a 2.0% decline in Asia/Pacific & Europe;
Loss per diluted share were $0.11, versus earnings per diluted share of $0.35 a year ago;
Adjusted earnings per diluted share were $0.01, compared to $0.31 a year ago;
Adjusted EBITDA of $1.7 million, compared to $6.6 million a year ago; and
Repurchased 103,391 shares.

*All comparisons are on a year over year basis and compare the fourth quarter of fiscal 2022 to the fourth quarter of fiscal 2021, unless otherwise noted.
Fiscal Year 2022 Summary**:

Revenue decreased 6.3% to $206.4 million.
Excluding the negative impact of foreign currency fluctuations, fiscal year 2022 revenue was down approximately 4.2%;
Revenue in Asia/Pacific & Europe increased 3.8% and revenue

Read more...

Nature’s Sunshine Products Q2 Revenue Down 4.4% To $104.2 Million

Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health and wellness company of high-quality herbal and nutritional products, reported financial results for the second quarter ended June 30, 2022.
Second Quarter 2022 Financial Summary vs. Same Year-Ago Quarter
Net sales were $104.2 million compared to $109.0 million.
GAAP net income was $1.0 million, or $0.03 per diluted share, compared to $6.8 million, or $0.32 per diluted share.
Adjusted EBITDA was $9.0 million compared to $13.4 million.
Management Commentary
“The challenges facing our world certainly remained in the second quarter,”
said Terrence Moorehead, CEO of Nature’s Sunshine.
“The devastating war in Ukraine, rampant inflation, supply chain pressures, and the lingering impact of COVID-19 hampered our vision to share the healing power of nature with everyone.
Despite the headwinds, our revenue was flat on a constant currency basis, driven by continued rapid growth in Asia and mitigated losses in Europe. We believe these outcomes illuminate the resilience of our brand, the power of our vision, and the advantages of our global presence.
“As we look to the remainder of the year, we recognize the volatility and uncertainty of the operating environment.
However, we will continue to invest in our five global growth strategies and support our partners

Read more...

Mannatech Q2 Revenue Down 17,7% To $35 Million

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2022.
Second Quarter End Results
Second quarter net sales for 2022 were $35.0 million, a decrease of $7.5 million, or 17.7%, as compared to $42.5 million in the second quarter of 2021.
Our net sales declined 11.3% on a constant dollar basis (see Non-GAAP Measures, below) as foreign exchange decreased GAAP net sales by $2.7 million, mostly due to the decline of the Korean Won and Japanese Yen.
During the second quarter, logistics in Hong Kong improved, and we were better able to deliver products to our customers. However, during the quarter, supply chain constraints worldwide continued to impact our sales. We have experienced a shortage of an ingredient used in some core products, and we have begun to move forward with our manufacturing partners with an alternative.
Second quarter operating income for 2022 was $0.9 million as compared to $2.0 million for the second quarter of 2021.
Net income was $0.7 million, or $0.34 per diluted share, for the second quarter of 2022, as compared to net income of $2.1 million, or $0.99 per diluted share,

Read more...

USANA Q2 Revenue Down 21% To $264 Million

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended July 2, 2022.

Second quarter net sales were $264 million as compared with $337 million during the second quarter of the prior year.
Second quarter diluted EPS totaled $1.00 versus $1.87 during the second quarter of 2021.
Company reiterates fiscal 2022 net sales and diluted EPS outlook of $1.015 billion to $1.065 billion and $3.85 to $4.45, respectively.

“As indicated in our preliminary results release on July 6th, we continue to experience COVID-related disruptions in several key markets, including mainland China. This caused participation in sales programs, Active Customer counts, and financial performance to come in lower than anticipated,”
said Kevin Guest, Chief Executive Officer and Chairman of the Board.
“Although many of these disruptions were outside of our control, and while we faced a tough year-over year comparable due to the timing of a successful sales program in 2021, our second quarter results were not up to our standards.
Nevertheless, we remain committed to our business strategy which we believe will deliver sustained, long-term growth in customer counts, net sales, and EPS.
Important elements of this strategy include

enhancing digital experience for our customers to improve the overall online shopping experience;
improving

Read more...

Zeta Pays $1,4 Million In Commission In The First Month

According to a Zeta press release:
As Allan Badilla stated,
“The 4.0 revolution will make history”, Zeta Group, in its first month has achieved great results and in just 30 days has set multiple records in the industry.
This revolution came to be a benchmark for leadership and economic growth in Latin America and the world, through the leadership of Allan Badilla, Zeta has achieved that its most recognized leaders reach ranks that seemed impossible in such a short time.
The first of these achievements was achieved in just 7 days by Allan Badilla, who reached the double diamond rank, earning a commission of $70,000, demonstrating, once again, that, thanks to his leadership and constant work, it is possible to achieve high-level results in record time.
By reaching this rank, Allan made way for one of its strongest leaders to achieve in just two weeks, being the first Diamond Z, the entrepreneur Miguel Posada, reached this rank in record time.
Following the example of the double diamond, Miguel continues stating that his purpose is to positively impact people and show them that results like this are a reflection of the effort and dedication of a leading organization in a million-dollar industry.
June continued to be a

Read more...

USANA Q2 Preliminary Sales Down 21% To $265 Million

USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the second quarter ended July 2, 2022, and provided an updated outlook for fiscal year 2022.
The Company anticipates that second quarter 2022 net sales will be approximately $265 million, which compares with $337 million in the prior-year period. Earnings per share for the quarter are expected to be approximately $1.05, which compares with $1.87 during the second quarter of 2021.
“Our sales performance during the second quarter was below expectations, as COVID-related lockdowns, restrictions, and other disruptions continued in mainland China and other markets,”
said Kevin Guest, Chief Executive Officer and Chairman of the Board.
“These challenges were particularly disruptive to the regional sales program we offered in several key markets during the quarter, and ultimately caused participation in the program, sales results and active customer counts to come in lower than anticipated.
Importantly, this program was designed to be a catalyst for sales and customer growth not only during the quarter, but also in the second half of the year. As a result of this and the continued uncertainty surrounding the operating environment going forward, we anticipate softer sales and customer counts in the second half of the year.”
“We continue to

Read more...

Herbalife Q1 Revenue Down 11% To $1.33 Billion Due To Pandamic

Is downtown-based Herbalife Nutrition Ltd. losing some of its mojo?
Maybe. Herbalife stock started sliding in February after its year-end earnings report and has lost nearly half of its value since then, substantially outpacing the overall drop in the markets.
Not helping was a first-quarter earnings report that was weak compared to 2021, with revenue down 11% to $1.33 billion and net income down about 33% to $98 million.
Herbalife sells a range of nutrition products using a network of more than 6 million distributors – which it calls members – in 95 countries. The products are for a variety of uses, including weight management, fitness, nutritional supplements and skin/body care.
In its earnings report issued on May 3, Herbalife attributed some of the sales slowdown to its newest group of distributors.
Herbalife Chief Executive John Agwunobi provided some additional insight in the teleconference call following the earnings release.
“Most of the distributors that joined Herbalife during the pandemic have never been to an in-person event, and there is no substitute for gathering in person for learning, collaborating and motivating,” he said.
Toward the end of the first quarter, Herbalife began reinstituting in-person distributor events.
“The interactive discussions, the face-to-face team building and the social elements that are

Read more...

Medifast – Optavia First Quarter Sales Up 22.6% To $417 Million

Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today reported results for the first quarter ended March 31, 2022.
First Quarter 2022 Highlights Compared to the Prior-Year Period

Revenue increased 22.6% to $417.6 million
21.7% growth in the number of active earning OPTAVIA Coaches to 63,900
Revenue per active earning OPTAVIA Coach increased 1.3% to $6,536
Net income increased 1.7% to $41.8 million
Earnings per diluted share (“EPS”) of $3.59, an increase of 3.8%
Annual revenue guidance raised to $1.78 billion to $1.84 billion and full-year EPS to $14.60 to $16.05

“Record quarterly revenues, sharp acceleration in coach metrics and an increase in our annual financial guidance are powerful indications of the underlying strength of our business.
We have record numbers of independent active earning OPTAVIA Coaches, helping us drive robust product demand and rapidly increasing digital engagement, and bolstering OPTAVIA to the #1 revenue share position among publicly traded companies in the weight management industry in the United States,”
said Dan Chard, Chairman and Chief Executive Officer of Medifast.
“We continue to take advantage of significant opportunities to further leverage our technological innovation and infrastructure. Through deeper integration of key technologies and data analytics, we are enhancing the OPTAVIA customer experience and enabling significant productivity gains for OPTAVIA Coaches.
All of this creates strong potential for further expansion into the broader

Read more...

LR Group 2021 Sales Up 4% To $310 Million

Group sales in 2021 increased by 4.0% to EUR 296.2 million (USA $ 310 Million)
EBITDA reported at the upper end of the earnings forecast at EUR 36.8 million
LR Global Holding GmbH, Europe’s leading digital social selling company in the area of high-quality health and care products, published its final, audited figures for financial year 2021 today, confirming the positive, preliminary figures for the past reporting year.
According to these figures, the LR Group was able to increase its sales (merchandise revenues) by 4.0% to EUR 296.2 million in financial year 2021 (previous year: EUR 284.9 million) and continue its growth course after an extraordinarily strong previous year. All regions contributed positively to the development of sales in 2021.
Furthermore, based on final figures, the LR Group achieved normalised EBITDA of EUR 41.6 million in financial year 2021, compared to EUR 42.5 million in the same period of the previous year.
In addition, the company improved its EBITDA reported slightly to EUR 36.8 million (previous year: EUR 36.7 million). This was at the upper end of the forecast for EBITDA reported of EUR 33 million to EUR 37 million for 2021.
“The LR Group developed successfully and further strengthened its market position in 2021.
This

Read more...

Prüvit Sales Topped $598 Million In 2021

Prüvit, one of the fastest growing health technology brands, was honored at the DSN 2022 Global 100 ceremony in Frisco, Texas for reaching $598 million in yearly revenue.
In addition to the Global 100 list, awards are given out in a variety of categories including leadership, lifetime achievement, meaningful global responsibility, customer centricity, and 2022 best places to work in direct selling, among others. The festivities are complimented by a special-edition print issue, and a networking dinner.
With a top-tier guest list made up of leading executives, the 2022 event was a tremendous success with a virtual broadcast making it possible for people all around the world to join in the experience.
The event is DSN’s celebration of the outstanding achievements of organizations and the executive leaders within the industry who have made big moves and experienced major growth over the past year. They are essentially the Oscars of direct selling with over 1,300 attendees, and more than 35 presenters with a total value of participating companies topping $20 billion.
It was a shining tribute to the unlimited potential of the whole community to grow and evolve into an even brighter future. With the wealth of knowledge of the thought leaders and executive innovators on the

Read more...